Privacy Policy

Pledge on Privacy

The term “personal data” as used in this Policy refers to information such as your name, birth date, e-mail address or mailing address that can be used to identify you. Lupin will not process your personal data without your consent. In processing your personal data, we pledge to fully comply with internationally recognized standards of privacy protection. In so doing, we ensure compliance by our staff with strict standards of security and confidentiality. The next sections explain how and when we collect personal data from you.

Intended Use of Personal Data

Most of our services do not require any form of registration, allowing you to visit our site without telling us who you are. However, some services may require registration. When you register with us, you may need to complete certain fields (some are required and some are optional), as well as choose a user name and password. In these situations, if you choose to withhold any personal data requested by us, it may not be possible for you to gain access to certain parts of the site and for us to respond to your query. Lupin processes personal data for specific and limited purposes, which we inform you about when we ask you for information. For example, we may collect and use personal data to provide you with products or services, to bill you for products and services you request, to market products and services which we think may be if interest to you, or to communicate with you for other purposes. Information you send to our customer service department is used only to help resolve your problem and is otherwise kept private. Lupin keeps your data only for as long as is reasonably needed for such purposes and in accordance with any applicable legal or ethical reporting or documentation retention requirements.

Non-Disclosure of Information

Lupin will not sell, share, or otherwise distribute your personal data to third parties outside the Lupin group. However, personal data may occasionally be transferred to third parties who act for or on behalf of Lupin, or in connection with the business of Lupin, for further processing in accordance with the purpose(s) for which the data were originally collected. Where disclosure of personal data to a third party is likely or necessary for whatever reason, Lupin will, wherever possible, endeavour to ensure that the disclosure and intended use of the data are clearly indicated. Such third parties may operate different privacy policies. However, we endeavour to ensure that such third parties provide the same level of protection as Lupin and, where appropriate, we will contractually require them to process data transferred only for the purposes expressly authorized by Lupin. We will not share with third parties any data about you that is sensitive (e.g., medical information) in the absence of your prior and explicit consent. Your consent may always be revoked at a later date. If consent is revoked Lupin may not be able to carry out certain requests made by you. Lupin will, where practicable, inform third parties to whom your data have been transferred of your withdrawal of consent.

Right of Access

You have the right to access and update your personal data or to require their deletion. We endeavor to ensure that personal data are up-to-date, accurate, and complete. If you wish to access or correct your personal data held by us, please contact the Webmaster. Your requests will be dealt with in a prompt and proper manner. No charge will be levied for complying with a correction request, however, for all other requests Lupin may charge a small fee to cover its costs. Requests to delete personal data will be subject to any applicable legal and ethical reporting or document filing or retention obligations imposed on Lupin.

Security and Confidentiality

To ensure the security and confidentiality of personal data that Lupin collects on-line, Lupin uses data networks protected, inter alia, by industry standard firewall and password protection. Access to personal data is restricted to those employees who have a need to use the data and who have been trained to handle such data properly and observe strict standards of confidentiality. If an employee breaches our policies and procedures he/she will be disciplined accordingly. Staff compliance with our policies and procedures is regularly audited and reviewed. While we cannot guarantee against any loss, misuse or alteration to data, we try to prevent such unfortunate occurrences.

Data Transfer Abroad

Lupin is a global enterprise and has databases in different jurisdictions. Lupin may transfer your data to one of its databases outside your country of domicile. If the level of privacy protection in a country does not comply with recognized international standards, we will ensure that data transfers to Lupin databases in that country are adequately protected and that the transfer of data to third parties in such countries will not occur unless we obtain your express consent to such transfer in advance.

Anonymous Data and “Cookies”

Most of the information that Lupin collects from its website(s) is anonymous information, such as the pages you visit and searches you perform. When you visit our website we do not collect any personal data from you unless otherwise authorized by you. Anonymous information is processed by Lupin to help improve the contents of the site and to compile aggregate statistics about individuals using our site for internal, market research purposes. In so doing, Lupin may install “cookies” that collect the first level domain name of the user (e.g., “bigmail.com” from an e-mail address of “john@bigmail.com”) and the date and time of access. “Cookies” by themselves cannot be used to discover the identity of the user. A “cookie” is a small piece of information, which is sent to your browser and stored on your computer's hard drive. Cookies do not damage your computer. You can set your browser to notify you when you receive a "cookie", this will enable you to decide if you want to accept it or not.

Spamming

Lupin does not condone “spamming”. Spamming is defined as sending unsolicited e-mails, usually of a commercial nature, in large numbers and repeatedly to individuals with whom the sender has had no previous contact or who have declined to receive such communications. In contrast, where Lupin believes that certain product, health, or other information is of importance to you it reserves the right to inform you by e-mail whilst giving you the choice of opting out of such service.

Personal Information and Children

Lupin will not knowingly collect, use or disclose personal data from a minor under the age of 13, without obtaining prior consent from a person with parental responsibility (e.g., a parent or guardian) through direct off-line contact. We will provide the parent with (i) notice of the specific types of personal data being collected from the minor, and (ii) the opportunity to object to any further collection, use, or storage of such information.

Links to Other Sites

This Privacy Policy applies only to Lupin websites to the exclusion of third party websites. Lupin may provide links to other websites, which we believe, may be of interest to our visitors. We aim to ensure that such websites are of the highest standard. However, due to the nature of the World Wide Web, Lupin cannot guarantee the standards of every website link it provides or be responsible for the contents of non-Lupin sites.

Contact Lupin

If you have any queries or complaints about our compliance with this Privacy Policy, or if you would like to make any recommendations or comments to improve the quality of our Privacy Policy, please contact the Webmaster. This privacy policy is effective as of October 15, 2003. We aim to constantly improve the tools available to you to manage the data that you provide to us. Please refer to this page from time to time to review these and other new features.

Legal Notice/Disclaimer

Lupin is the owner of all text, graphics and trademarks displayed on the site http://www.antararx.com, which is owned by Lupin. No reproduction of any part of this site may be made nor any part be modified or incorporated in any other work, except for strictly personal use. Lupin reserves all other rights pertaining to this site. The information on this site has been concluded in good faith and is for general purpose only. In spite of our best efforts, the information on this Web Site may become out of date. No representation or warranty is given as regards its accuracy or completeness. It should not be relied upon for any specific purpose. You must seek the advice of a health care professional to advise you on your specific situation This Web Site may link you to other Web Sites. We do not take any responsibility for, or accept any liability for, any information or opinion contained in any other third-party Web Site. Under no circumstance will Lupin or its subsidiaries, employees or agents be liable to any party for any loss, damage or expense arising out of any access to, or use of, this site. Lupin reserves the right, in its sole discretion, to terminate your access to all or part of this site, with or without notice.

 

INDICATIONS

Primary Hypercholesterolemia and Mixed Dyslipidemia: ANTARA® is indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG), and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hyperlipidemia or mixed dyslipidemia.

Hypertriglyceridemia: ANTARA® is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia. Improving glycemic control in diabetic patients showing fasting chylomicronemia will usually reduce fasting triglycerides and eliminate chylomicronemia thereby obviating the need for pharmacologic intervention. Markedly elevated levels of serum triglycerides (eg, >2,000 mg/dL) may increase the risk of developing pancreatitis. The effect of fenofibrate therapy on reducing this risk has not been adequately studied.

Important limitations of use: Fenofibrate was not shown to reduce coronary heart disease morbidity and mortality in patients with type 2 diabetes mellitus.

IMPORTANT SAFETY INFORMATION

ANTARA® is contraindicated in patients with severe renal impairment; active liver disease, including unexplained persistent liver function abnormalities; preexisting gallbladder disease; nursing mothers; and hypersensitivity to fenofibric acid, choline fenofibrate or fenofibrate.

The effect of ANTARA® on coronary heart disease morbidity and mortality and non-cardiovascular mortality has not been established.

Fibrates increase the risk for myopathy and are associated with rhabdomyolysis. The risks for myopathy and rhabdomyolysis are increased when fibrates are co-administered with a statin, particularly in the elderly and in patients with diabetes, renal failure, or hypothyroidism. The combined use of fibrates and statins should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk.

Patients should be advised to report promptly unexplained muscle pain, tenderness, or weakness. Discontinue ANTARA® if myopathy/myositis is suspected or diagnosed or if CPK levels are markedly elevated.

Fenofibrate at doses equivalent to 90 mg ANTARA® per day can increase serum transaminases. Monitor liver function regularly and discontinue treatment if enzyme levels persist above 3 times the normal limit.

Fenofibrate can reversibly elevate serum creatinine. Monitor renal function in patients with renal impairment.

Fenofibrate may lead to cholelithiasis. Discontinue ANTARA® if gallstones are found.

ANTARA® can potentiate the activity of oral anticoagulants. Monitoring and dosage adjustment of anticoagulants as needed are recommended.

Other precautions include pancreatitis, hematologic changes, hypersensitivity reactions, and venothromboembolic events.

The most common adverse reactions (>2% and ≥1% greater than placebo) are abnormal liver function tests, increased AST, increased ALT, increased CPK, and rhinitis.

This Web site and the information contained herein is intended for use by US residents only.